| 1 |
Giuseppe Alvaro |
Autifony Therapeutics Limited |
60 |
| 2 |
Keith Biggadike |
Glaxo Group Limited |
51 |
| 3 |
Diane Mary Coe |
Glaxo Group Limited |
40 |
| #4 |
George Stuart Cockerill |
Smithkline Beecham Limited |
39 |
| #5 |
Ann Louise Walker |
Glaxo Group Limited |
36 |
| #6 |
Deirdre Mary Bernadette Hickey |
Smithkline Beeacham P.L.C. |
35 |
| #7 |
John Liddle |
Glaxo Group Limited |
32 |
| #8 |
Julie Nicole Hamblin |
Glaxo Group Limited |
31 |
| #9 |
Agostino Marasco |
Autifony Therapeutics Limited |
29 |
| #10 |
Panayiotis Alexandrou Procopiou |
Glaxo Group Limited |
28 |
| #10 |
Paul Bamborough |
Glaxo Group Limited |
28 |
| #12 |
Alan Peter Lewis |
Glaxosmithkline Intellectual Property Development Limited |
27 |
| #12 |
Joelle Le |
Glaxo Group Limited |
27 |
| #14 |
Emmanuel Hubert Demont |
Glaxosmithkline Intellectual Property (No. 4) Limited |
24 |
| #15 |
Ian Baxter Campbell |
Glaxo Group Limited |
23 |
| #15 |
Jonathan Thomas Seal |
Glaxosmithkline Intellectual Property (No. 4) Limited |
23 |
| #15 |
Kevin Moulder |
Cancer Research Technology Limited |
23 |
| #18 |
Lee Andrew Harrison |
Glaxosmithkline Intellectual Property (No. 4) Limited |
22 |
| #18 |
Stephen John Atkinson |
Glaxosmithkline Intellectual Property (No. 4) Limited |
22 |
| #18 |
Simon John Fawcett MacDonald |
Biota Scientific Management Pty |
22 |
| #18 |
Vipulkumar Kantibhai Patel |
Smithkline Beecham Limited |
22 |
| #18 |
Gerard Martin Paul Giblin |
Glaxo Group Limited |
22 |
| #23 |
Jonathan Henry Ellis |
Glaxo Group Limited |
21 |
| #23 |
John David Harling |
Smithkline Beeacham P.L.C. |
21 |
| #23 |
Suzanne Elaine Keeling |
Glaxo Group Limited |
21 |
| #23 |
Anne Goubier |
Cancer Research Technology Limited |
21 |
| #27 |
Charlotte Jane Mitchell |
Glaxosmithkline |
20 |
| #27 |
Andrew Robert Pacey |
Limflow Gmbh |
20 |
| #29 |
Josephine Salimu |
Cancer Research Technology Limited |
19 |
| #29 |
Nigel James Parr |
Glaxo Group Limited |
19 |
| #29 |
Pascal Merchiers |
Cancer Research Technology Limited |
19 |
| #29 |
Beatriz Goyenechea Corzo |
Cancer Research Technology Limited |
19 |
| #33 |
Alexander G. Preston |
Glaxosmithkline Intellectual Property (No. 4) Limited |
17 |
| #34 |
Naimisha Trivedi |
Glaxosmithkline |
15 |
| #35 |
Michael David Woodrow |
Mission Therapeutics Limited |
14 |
| #35 |
Xiao Qing Lewell |
Glaxo Group Limited |
14 |
| #35 |
Nicola Mary Aston |
Glaxo Group Limited |
14 |
| #35 |
Tim Forshew |
Inivata |
14 |
| #35 |
Niall Andrew Anderson |
Glaxosmithkline Intellectual Property Development Limited |
14 |
| #35 |
Christopher Roland Wellaway |
Glaxosmithkline Intellectual Property (No. 4) Limited |
14 |
| #41 |
Stephen Sweeney |
Astrium Gmbh |
13 |
| #41 |
Matthew Lindon |
Glaxosmithkline Intellectual Property (No. 4) Limited |
13 |
| #41 |
Ian David Wall |
Glaxosmithkline Intellectual Property (No. 4) Limited |
13 |
| #41 |
Graham George Adam Inglis |
Glaxo Wellcome |
13 |
| #45 |
Alison Judith Redgrave |
Glaxo Group Limited |
12 |
| #45 |
John Poxon |
Xerox |
12 |
| #45 |
Paul Andrew Hamblin |
Glaxo Group Limited |
12 |
| #45 |
Arun Sridhar |
Galvani Bioelectronics Limited |
12 |
| #45 |
Nigel Richardson |
Nokia |
12 |
| #50 |
Dominique Amans |
Glaxosmithkline |
11 |